The important role of anti-Mullerian hormone (AMH) in the development of babies in the womb has been known for more than 50 years. In male embryos it is responsible for shrinking the ‘Müllerian ducts’, from which the fallopian tubes, uterus and the upper part of the vagina develop in female embryos. In the 1980s AMH was detected in women of reproductive age, and the first publications using AMH to assess ovarian reserve appeared in the late 1990s.
The anti-Müllerian hormone is an excellent laboratory parameter for assessing ovarian reserves, especially if you want to have children, and an important factor for assessing individual chances of conceiving. The AMH value of a woman who wishes to have children shows whether the biological clock is already ahead or potentially slow. A rough prognosis is possible through our AMH diagnostics in Linz.
The age of the woman, her AMH level and the duration time trying to conceive are the most important factors that decide whether to take an active or wait-and-see approach to starting a family. Therefore, at the Kinderwunsch Institut Dr Loimer, the evaluation of AMH is routine for all women who want to have children from the age of 30, the value is included in an individual consultation.